Printer Friendly

Colorectal cancer screening.

The CLIA-waived Hemosure[R] Immunochemical Fecal Occult Blood Test (iFOBT) offers a notable consideration in that there are no drug or diet restrictions. It is a rapid, convenient, and odorless test for the determination of human hemoglobin in feces, typically used for colorectal cancer screening. The one-step immunological fecal occult blood test is a qualitative, sandwich dye conjugate immunoassay and employs a unique combination of monoclonal and polyclonal antibodies to selectively identify hemoglobin in test samples with a high degree of sensitivity. In less than five minutes, elevated levels of human hemoglobin as low as 50 ng hHB/ mL can be detected and positive results for high levels of hemoglobin can be seen in the test as early as one or two minutes.

Hemosure, Inc.


COPYRIGHT 2012 NP Communications, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Industry spotligt
Publication:Medical Laboratory Observer
Date:Apr 1, 2012
Previous Article:Reduce the number of false positive test results.
Next Article:John Ledek guides BD's efforts to offer labs innovative solutions for Preanalytical Systems.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |